O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa

scientific article published on May 1, 2003

O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.41.5.2158-2160.2003
P953full work available at URLhttps://europepmc.org/articles/pmc154700?pdf=render
https://europepmc.org/articles/PMC154700
https://europepmc.org/articles/PMC154700?pdf=render
https://doi.org/10.1128/jcm.41.5.2158-2160.2003
https://journals.asm.org/doi/pdf/10.1128/JCM.41.5.2158-2160.2003
P932PMC publication ID154700
P698PubMed publication ID12734267

P50authorKarine FaureQ47503632
P2093author name stringTeiji Sawa
Temitayo Ajayi
David Shimabukuro
Jeanine P. Wiener-Kronish
Leonard R. Allmond
P2860cites workAmerican Journal of PhysiologyQ2160146
Prognostic Factors of Pneumonia Requiring Admission to the Intensive Care UnitQ64130019
Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infectionsQ70089750
Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodesQ71664205
Epidemiological investigation of Pseudomonas aeruginosa nosocomial bacteraemia isolates by PCR-based DNA fingerprinting analysisQ71779504
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosaQ74568549
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogenQ22122393
Type III protein secretion systems in bacterial pathogens of animals and plantsQ24548602
Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathwayQ28492720
Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbitsQ28492960
Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe SepsisQ33489156
Type III secretion machines: bacterial devices for protein delivery into host cellsQ33639326
Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study GroupQ33661208
Genetics of O-antigen biosynthesis in Pseudomonas aeruginosaQ33728775
In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infectionsQ33756310
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumoniaQ33853738
Production of exoenzyme S during Pseudomonas aeruginosa infections of burned miceQ34086029
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S.Q35567132
Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulonQ35632593
Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosisQ36532113
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III systemQ36809802
Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11.Q37296163
Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosaQ40199320
Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sitesQ40206580
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infectionsQ40706274
Ventilator-associated pneumonia due to Pseudomonas aeruginosaQ40945554
Genetic analysis of exoenzyme S expression by Pseudomonas aeruginosaQ40966513
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injuryQ41095866
The exoenzyme S regulon of Pseudomonas aeruginosaQ41487139
The contribution of exoproducts to virulence of Pseudomonas aeruginosaQ43958510
Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patienQ44016762
Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosaQ44359602
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.Q44912919
Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.Q46005216
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectPseudomonas aeruginosaQ31856
P304page(s)2158-2160
P577publication date2003-05-01
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleO-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa
O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa
P478volume41

Reverse relations

cites work (P2860)
Q41671547Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa
Q51732617Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
Q30416945Identification of the mutation responsible for the temperature-sensitive lipopolysaccharide O-antigen defect in the Pseudomonas aeruginosa cystic fibrosis isolate 2192.
Q30443179Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections
Q30430870Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection
Q34044909Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235.
Q33754176Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Q43181958Pseudomonas aeruginosa: so many virulence factors, so little time
Q38242626Respiratory infections in patients undergoing mechanical ventilation
Q34999695Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa.
Q41129552Serotyping and Cross-Reactivity's Between Different Pseudomonas aeruginosa Isolates Prevalent in Iran
Q42282641Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital.
Q30441643Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice
Q26852817Vaccines for Pseudomonas aeruginosa: a long and winding road

Search more.